Connect with us


Covetrus to Acquire VCP Veterinary Wellness Platform

More than 350,000 pets benefit from wellness plans enabled by VCP.




PORTLAND, ME, and IRVINE, CA — Covetrus, a company focused on animal-health technology and services, plans to acquire VCP, a veterinary wellness plan administration platform.

Financial terms of the deal were not disclosed. The acquisition is expected to close in the third quarter, subject to customary closing conditions.

VCP serves about 1,000 veterinary practices with more than 350,000 pets currently benefiting from wellness plans enabled by VCP. The acquisition is expected to close in the third quarter, subject to customary closing conditions.


More from the press release:

VCP’s technology platform and infrastructure will afford Covetrus new ways to provide today’s veterinarians with tools to foster stronger relationships with their pet parent clients and deliver better business and healthcare outcomes. VCP’s solutions help veterinarians serve the growing number of pet parents seeking holistic, highly tailored wellness plans centered around their trusted veterinarian.

As a leading wellness solutions provider, VCP’s technology helps veterinarians deliver comprehensive wellness, treatment and lifestyle plans for their clients. Plans powered by VCP feature everything from preventative services, dental care and diagnostics to boarding and grooming. Integrating the VCP platform with Covetrus’ robust practice management and prescription management software will enable customized wellness plans to meet the unique needs of every family and support an enhanced veterinary practice and pet parent experience.

“Modern pet parents are serious about wellness, and that means delivering the right medicine, services and products at the right price and the right time,” says Ben Wolin, Covetrus president and chief executive officer. “Covetrus is strategically positioned to help veterinarians deliver proactive and holistic healthcare via membership programs with a seamless integration into our leading practice management and prescription management solutions. By adding VCP’s technology to our software portfolio, we’re making wellness truly accessible for both practices and pet parents, which is key to helping veterinarians strengthen their relationships with their clients, improve clinical quality and extend affordable care.”

Pet wellness has grown to an estimated $50 billion market in the United States and is currently experiencing rapid adoption. For veterinarians looking to stand out from the competition and drive better practice and patient health, tech-driven wellness plans deliver exceptional experiences that strengthen bonds with both clients and patients. Practices adopting the VCP platform reported up to 10% revenue growth in the first year, with ongoing year-over-year growth and significant increases in spending per pet over time.

“Covetrus is a natural fit as VCP prepares for the next stage of our journey,” said Bob Richardson, VCP co-founder and president, who will continue in his role. “Covetrus offers the opportunity to bring our comprehensive wellness solution to the forefront by integrating with their powerful practice management solutions. This integration will deliver new levels of ease and convenience for clinics and facilitate more care. In addition, it will drive pet care education and enable convenient home delivery for pet parents looking for easier accessibility, value and a better overall experience. We are beyond excited to better deliver the Business of Wellness and the resulting benefits to countless pets, pet parents and veterinary practitioners in the years ahead.”

Financial terms of the transaction were not disclosed. The transaction is not expected to have a material impact on Covetrus’ previously announced 2021 financial guidance.

White and Williams LLP is acting as legal advisor to Covetrus, and Lincoln International LLC is acting as financial advisor. Bryan Cave Leighton Paisner LLP is acting as legal advisor to VCP, and Houlihan Lokey is acting as its exclusive financial advisor.




Sponsored by Cogent Solutions Group

Reduce Your Pet’s Hip & Joint Discomfort with the Most Researched Hyaluronan on the Market

Nearly 60% of dogs and 90% of cats suffer from joint discomfort. Trixsyn joint supplement contains a patented and proven hyaluronic acid molecule for maximum efficacy to promote joint, bone, soft tissue, and cartilage health, keeping your pet feeling comfortable, for longer. Trixsyn is veterinarian recommended, safe and all-natural, and contains research-proven ingredients. Get your paws on the most-researched hyaluronic acid on the market. Learn more at

Promoted Headlines

Most Popular